PatientsVille.com Logo

PatientsVille

Bufferin Side Effects

Common Bufferin Side Effects


The most commonly reported Bufferin side effects (click to view or check a box to report):

Death (11)
Malaise (8)
Dyspnoea (7)
Cardiac Failure Congestive (7)
Arthritis (7)
Abdominal Pain Upper (7)
Cough (6)
Chest Pain (6)
Diarrhoea (6)
Fall (6)
Blood Lactate Dehydrogenase Increased (5)
Anaemia (5)
Blood Pressure Increased (5)
Arthralgia (5)
Brain Natriuretic Peptide Increased (5)
Cataract (5)
Dilatation Ventricular (5)
Diabetes Mellitus (5)
Hypertension (4)
Haemoglobin Decreased (4)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Bufferin Side Effects Reported to FDA

The following Bufferin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Bufferin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Chronic Obstructive Pulmonary Disease, Breath Sounds Abnormal, Wheezing, Productive Cough, Tachypnoea, Lung Hyperinflation, Nasopharyngitis, Throat Irritation
This is a report of a 61-year-old male patient (weight: NA) from COUNTRY NOT SPECIFIED, suffering from the following symptoms/conditions: NA, who was treated with Bufferin (dosage: 100 Mg, Qd, start time: NS), combined with:
  • Citalopram (20 Mg, Qd)
  • Carvedilol (6.25 Mg, Bid (every 12 Hours))
  • Budesonide, Formoterol Fumarate
  • Furosemide (20 Mg, Qd)
  • Spironolactone (25 Mg, Qd)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Chronic Obstructive Pulmonary Disease
  • Breath Sounds Abnormal
  • Wheezing
  • Productive Cough
  • Tachypnoea
  • Lung Hyperinflation
  • Nasopharyngitis
  • Throat Irritation
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bufferin treatment in male patients, resulting in chronic obstructive pulmonary disease side effect.

Fall, Intervertebral Disc Protrusion, Movement Disorder
This report suggests a potential Bufferin Fall, Intervertebral Disc Protrusion, Movement Disorder side effect(s) that can have serious consequences. A 75-year-old female patient (weight: NA) from BR was diagnosed with the following symptoms/conditions: NA and used Bufferin (dosage: 9 Df, 1 Df At Morning And 2 Df Every 6 Hours) starting NS. Soon after starting Bufferin the patient began experiencing various side effects, including:
  • Fall
  • Intervertebral Disc Protrusion
  • Movement Disorder
Drugs used concurrently: NA. Although Bufferin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as fall, may still occur.

Diarrhoea, Hypotension, Dyspepsia, Malaise, Vomiting, Abdominal Pain Upper
This Diarrhoea, Hypotension, Dyspepsia, Malaise, Vomiting, Abdominal Pain Upper problem was reported by a consumer or non-health professional from BR. A 74-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: cardiac disorder. On 2006 this consumer started treatment with Bufferin (dosage: 2 Df, Qd). The following drugs were being taken at the same time:
  • Acetylsalicylic Acid (Unk, Unk)
When commencing Bufferin, the patient experienced the following unwanted symptoms/side effects:
  • Diarrhoea
  • Hypotension
  • Dyspepsia
  • Malaise
  • Vomiting
  • Abdominal Pain Upper
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as diarrhoea, may become evident only after a product is in use by the general population.

Dengue Fever
This is a report of a 67-year-old female patient (weight: NA) from BR. The patient developed the following symptoms/conditions: cardiovascular disorder,diabetes mellitus and was treated with Bufferin (dosage: 81 Mg, Qd) starting NS. Concurrently used drugs:
  • Insulin (Unk, Qhs)
  • Metformin (3 Df, Qd)
  • Atenolol (1 Df, Qd)
  • Diovan (2 Df, Qd)
Soon after that, the consumer experienced the following side effects:
  • Dengue Fever
This opens a possibility that Bufferin treatment could cause the above reactions, including dengue fever, and some female subjects may be more susceptible.


Cardiac Arrest, Myocardial Infarction, Asthenia, Chest Pain, Dyspnoea, Hyperhidrosis, Coronary Artery Insufficiency, Lung Disorder, Rhinorrhoea
A male patient (weight: NA) from COUNTRY NOT SPECIFIED with the following symptoms/conditions: cardiac disorder started Bufferin treatment (dosage: 1 Df Daily) on NS. Soon after starting Bufferin treatment, the subject experienced various side effects, including:
  • Cardiac Arrest
  • Myocardial Infarction
  • Asthenia
  • Chest Pain
  • Dyspnoea
  • Hyperhidrosis
  • Coronary Artery Insufficiency
  • Lung Disorder
  • Rhinorrhoea
Concurrently used drugs:
  • Monocordil (1 Tablet At Morning And 2 Tablets At Night)
  • Monocordil (1 Df, At Night)
  • Digoxin (0.5 Df, Unk)
  • Enalapril (1 Df, Every 12 Hours)
  • Furosemide (1 Df, Daily)
  • Simvastatin (1 Df, Every 12 Hours)
  • Captopril (1 Df, Every 12 Hours)
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Bufferin.

Carotid Arteriosclerosis, Anal Haemorrhage
A female patient from BR (weight: NA) experienced symptoms, such as: cerebrovascular accident and was treated with Bufferin(dosage: 1 Df, Unk). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Carotid Arteriosclerosis
  • Anal Haemorrhage
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Bufferin efficacy:
  • Aspirina Prevent (1 Df, Daily)
  • Micardis (1 Df, Unk)


Osteoarthritis, Arthralgia, Parkinson^s Disease, Diabetes Mellitus, Gait Disturbance, Stress, Feeling Hot
In this report, Bufferin was administered for the following condition: cardiovascular disorder.A 83-year-old male consumer from BR (weight: NA) started Bufferin treatment (dosage: 81 Mg, Daily) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Osteoarthritis
  • Arthralgia
  • Parkinson^s Disease
  • Diabetes Mellitus
  • Gait Disturbance
  • Stress
  • Feeling Hot
A possible interaction with other drugs could have contributed to this reaction:
  • Acetylsalicylic Acid (2 Df, Daily)
  • Propranolol (1 Df, Daily)
  • Somalgin Cardio (1 Df, Daily)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Bufferin treatment could be related to the listed above side effect(s).

Cerebrovascular Accident, Myocardial Infarction, Haemorrhoids, Haemorrhage, Chest Pain, Rectal Haemorrhage, Flatulence, Back Pain, Pain In Extremity
This is a report of the following Bufferin side effect(s):
  • Cerebrovascular Accident
  • Myocardial Infarction
  • Haemorrhoids
  • Haemorrhage
  • Chest Pain
  • Rectal Haemorrhage
  • Flatulence
  • Back Pain
  • Pain In Extremity
A 62-year-old female patient from US (weight: NA) presented with the following condition: pain,hypoaesthesia and received a treatment with Bufferin (dosage: 2 Df, Unk) starting: 1970.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Bufferin treatment could be associated with the listed above side effect(s).

Chronic Obstructive Pulmonary Disease
This Bufferin report was submitted by a 76-year-old male consumer from BR (weight: NA). The patient was diagnosed with: pain in extremity and Bufferin was administered (dosage: 2 Df) starting: NS. The consumer developed a set of symptoms:
  • Chronic Obstructive Pulmonary Disease
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Bufferin treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Lupus-like Syndrome, Concomitant Disease Aggravated, Thrombosis, Depression, Diarrhoea, Headache, Abdominal Pain Upper
This is a report of a possible correlation between Bufferin use and the following symptoms/side effect(s):
  • Lupus-like Syndrome
  • Concomitant Disease Aggravated
  • Thrombosis
  • Depression
  • Diarrhoea
  • Headache
  • Abdominal Pain Upper
which could contribute to an assessment of Bufferin risk profile.A 65-year-old female consumer from BR (weight: NA) was suffering from coagulopathy and was treated with Bufferin (dosage: 1 Df, Qd) starting May 23, 2013.Other concurrent medications:
  • Somalgin
  • Puran T4 (1 Df, Qd)
  • Omeprazole (2 Df Daily)
  • Omeprazole
  • Calcort (1 Df In The Morning)
  • Sustrate (2 Df, Qd)
  • Atenol (1 Df, Qd)
  • Citalopram (1.5 Df, Qd)
The patient was hospitalized.

Cardiovascular Insufficiency, Malaise, Spinal Fracture, Spinal Pain, Abdominal Pain Upper, Vomiting
A female patient from BR (weight: NA) presented with the following symptoms: deep vein thrombosis and after a treatment with Bufferin (dosage: 81 Mg, Daily) experienced the following side effect(s):
  • Cardiovascular Insufficiency
  • Malaise
  • Spinal Fracture
  • Spinal Pain
  • Abdominal Pain Upper
  • Vomiting
The treatment was started on NS. Bufferin was used in combination with the following drugs:
  • Somalgin (81 Mg, Daily)
  • Simvastatin (40 Mg, Daily)
  • Pantoprazole (40 Mg, Daily)
  • Calcium (1 Df, Daily)
  • Addera D3 (5 Drp, Daily)
  • Proepa (1 Df, Qd)
  • Rivotril (1 Df, Qd At Night)
  • Genteal (1 Drp, Qd At Night)
The patient was hospitalized.This report could alert potential Bufferin consumers.

Hiatus Hernia, Blood Pressure Decreased, Cataract, Ulcer, Blood Pressure Systolic Increased, Gastrooesophageal Reflux Disease, Asthenia
In this report, a female patient from BR (weight: NA) was affected by a possible Bufferin side effect.The patient was diagnosed with carotid artery occlusion,hypertension,off label use. After a treatment with Bufferin (dosage: 1 Df, Daily, start date: 2007), the patient experienced the following side effect(s):
  • Hiatus Hernia
  • Blood Pressure Decreased
  • Cataract
  • Ulcer
  • Blood Pressure Systolic Increased
  • Gastrooesophageal Reflux Disease
  • Asthenia
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Bufferin treatment.

Uterine Cancer, Hypersensitivity, Rash, Nasal Congestion, Feeling Abnormal
This is a report of a 86-year-old female patient from US (weight: NA), who used Bufferin (dosage: NA) for a treatment of NA. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Uterine Cancer
  • Hypersensitivity
  • Rash
  • Nasal Congestion
  • Feeling Abnormal
The following drugs could possibly have interacted with the Bufferin treatment
  • Acetylsalicylic Acid
  • Pramin
Taken together, these observations suggest that a Bufferin treatment could be related to side effect(s), such as Uterine Cancer, Hypersensitivity, Rash, Nasal Congestion, Feeling Abnormal.

Granuloma Skin, Pyoderma, Arthritis
This granuloma skin side effect was reported by a consumer or non-health professional from CA. A 64-year-old female patient (weight:NA) experienced the following symptoms/conditions: pain. The patient was prescribed Bufferin Extra Strength (dosage: NA), which was started on NS. Concurrently used drugs: NA. When starting to take Bufferin Extra Strength the consumer reported the following symptoms:
  • Granuloma Skin
  • Pyoderma
  • Arthritis
These side effects may potentially be related to Bufferin Extra Strength.

Carotid Artery Thrombosis, Dizziness, Balance Disorder, Malaise
This is a Bufferin side effect report of a 68-year-old male patient (weight:NA) from BR, suffering from the following symptoms/conditions: polycythaemia, who was treated with Bufferin (dosage:81 Mg, Qd, start time: NS), combined with:
  • Crestor
, and developed a serious reaction and a carotid artery thrombosis side effect. The patient presented with:
  • Carotid Artery Thrombosis
  • Dizziness
  • Balance Disorder
  • Malaise
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Bufferin treatment in male patients suffering from polycythaemia, resulting in carotid artery thrombosis.

Influenza
This report suggests a potential Bufferin influenza side effect(s) that can have serious consequences. A 55-year-old female patient from BR (weight:NA) was diagnosed with the following health condition(s): blood disorder,infarction,heart rate,hypertension and used Bufferin (dosage: 1 Df, Unk) starting 2010. Soon after starting Bufferin the patient began experiencing various side effects, including:
  • Influenza
Drugs used concurrently:
  • Clopidogrel
  • Atenolol (50 Mg, Unk)
  • Captopril (25 Mg, Unk)
Although Bufferin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as influenza, may still occur.

Diabetes Mellitus, Incorrect Dose Administered
This diabetes mellitus problem was reported by a consumer or non-health professional from US. A 65-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): pain in extremity.On NS a consumer started treatment with Bufferin Extra Strength (dosage: 1 Df, Daily). The following drugs/medications were being taken at the same time: NA. When commencing Bufferin Extra Strength, the patient experienced the following unwanted symptoms /side effects:
  • Diabetes Mellitus
  • Incorrect Dose Administered
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as diabetes mellitus, may become evident only after a product is in use by the general population.

Bone Disorder, Asthma, Dyspnoea, Arthralgia, Feeling Hot, Bronchitis
This is a Bufferin side effect report of a female patient (weight: NA) from BR. The patient developed the following symptoms/conditions: cardiovascular disorder and was treated with Bufferin (dosage: 2 Df, Daily) starting Mar 20, 2013. Concurrently used drugs:
  • Somalgin (2 Df, Daily)
  • Glifage (2 Df, Daily)
  • Insulin Novolin (70 Ml, Daily)
  • Artrodar (2 Df, Daily)
Soon after that, the consumer experienced the following of symptoms:
  • Bone Disorder
  • Asthma
  • Dyspnoea
  • Arthralgia
  • Feeling Hot
  • Bronchitis
This opens a possibility that Bufferin could cause bone disorder and that some female patients may be more susceptible.

Abortion Spontaneous, Maternal Exposure During Pregnancy
A 33-year-old female patient (weight: NA) from BR with the following symptoms: prophylaxis started Bufferin treatment (dosage: 1 Df, Qd) on NS. Soon after starting Bufferin treatment, the consumer experienced several side effects, including:
  • Abortion Spontaneous
  • Maternal Exposure During Pregnancy
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Bufferin side effects, such as abortion spontaneous.

Infarction
This infarction side effect was reported by a consumer or non-health professional from BR. A 78-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Bufferin (dosage: NA), which was started on NS. Concurrently used drugs: NA..When starting to take Bufferin the consumer reported symptoms, such as:
  • Infarction
These side effects may potentially be related to Bufferin.

Cataract
This is a report of a 85-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: blood disorder, who was treated with Bufferin Regular Strength (dosage: 1 Df, Every Day, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Cataract
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bufferin Regular Strength treatment in female patients, resulting in cataract side effect.

Gastrointestinal Infection, Dyspepsia, Gastrointestinal Disorder
This report suggests a potential Bufferin Gastrointestinal Infection, Dyspepsia, Gastrointestinal Disorder side effect(s) that can have serious consequences. A 77-year-old female patient (weight: NA) from BR was diagnosed with the following symptoms/conditions: myocardial infarction and used Bufferin (dosage: 1 Df, Daily) starting NS. Soon after starting Bufferin the patient began experiencing various side effects, including:
  • Gastrointestinal Infection
  • Dyspepsia
  • Gastrointestinal Disorder
Drugs used concurrently:
  • Aas (2 Df, Daily)
  • Somalgin (1 Df, Daily)
  • Insuline (35 Mg, (20 Mg At Morning And 15 Mg At Night Before Dinner))
  • Sustrate (3 Df, Daily)
  • Cardizem (2 Df, Daily)
  • Labirin (1 Df, At Night)
  • Diovan Hct (2 Df, Daily)
  • Venalot (1 Df, Daily)
Although Bufferin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as gastrointestinal infection, may still occur.

Hypotension, Pleural Effusion, Heart Rate Abnormal, Organ Failure, Swelling, Breast Enlargement, Liver Disorder
This Hypotension, Pleural Effusion, Heart Rate Abnormal, Organ Failure, Swelling, Breast Enlargement, Liver Disorder problem was reported by a consumer or non-health professional from BR. A 80-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: cardiac disorder. On NS this consumer started treatment with Bufferin (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Bufferin, the patient experienced the following unwanted symptoms/side effects:
  • Hypotension
  • Pleural Effusion
  • Heart Rate Abnormal
  • Organ Failure
  • Swelling
  • Breast Enlargement
  • Liver Disorder
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as death, may become evident only after a product is in use by the general population.

Colon Cancer, Cystitis, Urinary Tract Infection, Urine Abnormality
This is a report of a 65-year-old male patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Bufferin Regular Strength (dosage: NA) starting 201201. Concurrently used drugs:
  • Celexa (20 Mg, Qd)
Soon after that, the consumer experienced the following side effects:
  • Colon Cancer
  • Cystitis
  • Urinary Tract Infection
  • Urine Abnormality
This opens a possibility that Bufferin Regular Strength treatment could cause the above reactions, including colon cancer, and some male subjects may be more susceptible.

Deafness
A 76-year-old female patient (weight: NA) from BR with the following symptoms/conditions: cardiac murmur,atrioventricular block,off label use,anxiety,hypertension started Bufferin treatment (dosage: 1 Df, At Morning) on NS. Soon after starting Bufferin treatment, the subject experienced various side effects, including:
  • Deafness
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Bufferin.

1 of 8 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Bufferin Side Effects

    Did You Have a Bufferin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Bufferin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Bufferin Safety Alerts, Active Ingredients, Usage Information

    NDC0067-6424
    TypeHUMAN OTC DRUG
    Proprietary NameBUFFERIN LOW DOSE BUFFERED ASPIRIN
    NameASPIRIN
    Dosage FormTABLET
    RouteORAL
    On market since20110311
    LabelerNovartis Consumer Health, Inc.
    Active Ingredient(s)ASPIRIN
    Strength(s)81
    Unit(s)mg/1
    Pharma Class

    More About Bufferin

    Side Effects reported to FDA: 192

    Bufferin safety alerts: No

    Reported deaths: 14

    Reported hospitalizations: 54

    Latest Bufferin clinical trials

    Bufferin Reviews

    No reviews, be a first to report a side effect via side effect reporting form